is januvia a glp 1 agonist New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1-RA and DPP-4 inhibitors in

Read Important Safety and Prescribing Information, including Boxed Warning.

Background Establishing whether there is a potential relationship between glucagon-like peptide 1 receptor agonists (GLP-1RAs) and suicidal or self-injurious behaviors (SSIBs) is crucial for public safety

Significant reductions in HbA1c at 6 months (0.7%

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

This product is not intended to diagnose, treat, cure, or prevent any disease